Santanu Maji Selected Research

Santanu Maji Research Topics

16	Neoplasms (Cancer) 11/2023 - 06/2015
8	Melanoma (Melanoma, Malignant) 11/2023 - 01/2020
7	Neoplasm Metastasis (Metastasis) 11/2023 - 11/2019
2	Prostatic Neoplasms (Prostate Cancer) 11/2023 - 11/2019
2	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 01/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2023
1	Adenocarcinoma 11/2023
1	Experimental Melanoma 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Carcinogenesis 01/2020
1	Leukemia 01/2020
1	Liver Neoplasms (Liver Cancer) 01/2020
1	Neuroblastoma 01/2020
1	Squamous Cell Carcinoma of Head and Neck 12/2019
1	Latent Infection 01/2014
1	Kaposi Sarcoma (Kaposi's Sarcoma) 01/2014

8	Proteins (Proteins, Gene)FDA Link 10/2023 - 01/2014
6	SynteninsIBA 11/2023 - 11/2019
5	SyndecansIBA 11/2023 - 01/2020
5	Carrier Proteins (Binding Protein)IBA 11/2023 - 01/2020
2	CytokinesIBA 01/2022 - 02/2021
2	Cisplatin (Platino)FDA LinkGeneric 12/2021 - 12/2019
1	platelet-derived growth factor AIBA 11/2023
1	Poly CIBA 11/2023
1	Double-Stranded RNA (RNA, Double Stranded)IBA 11/2023
1	Matrix Metalloproteinases (MMPs)IBA 10/2023
1	NexusIBA 10/2023
1	Transcription Factors (Transcription Factor)IBA 03/2022
1	GATA2 Transcription FactorIBA 03/2022
1	interleukin-24 (ST16)IBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	InterleukinsIBA 12/2021
1	Interleukin-10 (Interleukin 10)IBA 12/2021
1	InterferonsIBA 12/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Temozolomide (Temodar)FDA LinkGeneric 01/2020
1	Lumefantrine FDA Link 01/2020
1	Antimalarials (Antimalarial Agents)IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	triptolideIBA 12/2019
1	Fluorouracil (Carac)FDA LinkGeneric 12/2019
1	Docetaxel (Taxotere)FDA Link 12/2019
1	Celecoxib (Celebrex)FDA Link 06/2015
1	1,1',6,6',7,7'- hexahydroxy- 3,3'- dimethyl- N5- (2- phenylpropyl)- N5'- (2- phenylpropyl)- 2,2'- binaphthyl- 5,5'- dicarboxamideIBA 06/2015
1	CarcinogensIBA 06/2015
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 06/2015
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 01/2014
1	latency-associated nuclear antigenIBA 01/2014